Winton Group LTD Xencor Inc Transaction History

Winton Group LTD

$1.31 Billion
Q3 2024

A detailed history of Winton Group LTD transactions in Xencor Inc stock. As of the latest transaction made, Winton Group LTD holds 55,747 shares of XNCR stock, worth $1.41 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

55,747

Previous 46,481 19.94%

Holding current value

$1.41 Million

Previous $879,000 27.53%

% of portfolio

0.09%

Previous 0.06%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$15.7 - $21.65 $145,476 - $200,608	9,266 Added 19.94%	55,747 $1.12 Million
Q2 2024 Aug 09, 2024	BUY	$18.21 - $24.5 $34,289 - $46,133	1,883 Added 4.22%	46,481 $879,000
Q1 2024 May 14, 2024	BUY	$18.65 - $26.52 $400,956 - $570,153	21,499 Added 93.07%	44,598 $986,000
Q4 2023 Feb 12, 2024	BUY	$16.53 - $21.42 $73,294 - $94,976	4,434 Added 23.76%	23,099 $490,000
Q3 2023 Nov 13, 2023	BUY	$20.08 - $25.39 $151,162 - $191,135	7,528 Added 67.59%	18,665 $376,000
Q2 2023 Aug 14, 2023	SELL	$24.77 - $29.9 $54,122 - $65,331	-2,185 Reduced 16.4%	11,137 $278,000
Q1 2023 May 12, 2023	SELL	$25.95 - $36.95 $562,492 - $800,928	-21,676 Reduced 61.93%	13,322 $371,000
Q4 2022 Feb 14, 2023	BUY	$24.79 - $30.86 $211,830 - $263,698	8,545 Added 32.3%	34,998 $911,000
Q3 2022 Nov 10, 2022	SELL	$24.62 - $32.44 $216,237 - $284,920	-8,783 Reduced 24.93%	26,453 $687,000
Q2 2022 Aug 10, 2022	BUY	$19.74 - $29.01 $235,083 - $345,480	11,909 Added 51.05%	35,236 $964,000
Q1 2022 May 11, 2022	BUY	$26.68 - $41.63 $397,291 - $619,912	14,891 Added 176.52%	23,327 $622,000
Q4 2021 Feb 10, 2022	SELL	$33.67 - $43.44 $783,197 - $1.01 Million	-23,261 Reduced 73.39%	8,436 $338,000
Q3 2021 Oct 28, 2021	SELL	$30.65 - $35.68 $12,076 - $14,057	-394 Reduced 1.23%	31,697 $1.04 Million
Q2 2021 Aug 10, 2021	SELL	$34.33 - $44.68 $29,043 - $37,799	-846 Reduced 2.57%	32,091 $1.11 Million
Q1 2021 Jul 21, 2021	SELL	$40.81 - $53.88 $191,154 - $252,373	-4,684 Reduced 12.45%	32,937 $1.42 Million
Q4 2020 Feb 12, 2021	SELL	$36.63 - $47.63 $3.39 Million - $4.41 Million	-92,496 Reduced 71.09%	37,621 $1.64 Million
Q3 2020 Oct 30, 2020	SELL	$30.09 - $43.02 $1.59 Million - $2.28 Million	-52,999 Reduced 28.94%	130,117 $5.05 Million
Q2 2020 Aug 05, 2020	SELL	$27.76 - $33.42 $862,059 - $1.04 Million	-31,054 Reduced 14.5%	183,116 $5.93 Million
Q1 2020 May 11, 2020	SELL	$20.69 - $37.79 $1.06 Million - $1.93 Million	-51,134 Reduced 19.27%	214,170 $6.4 Million
Q4 2019 Feb 13, 2020	BUY	$32.75 - $41.43 $7.86 Million - $9.95 Million	240,151 Added 954.76%	265,304 $9.12 Million
Q3 2019 Nov 08, 2019	BUY	$33.73 - $46.27 $848,410 - $1.16 Million	25,153 New	25,153 $848,000
Q2 2019 Jul 08, 2019	SELL	$29.6 - $40.93 $246,656 - $341,069	-8,333 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$27.85 - $38.09 $232,074 - $317,403	8,333 New	8,333 $259,000

Others Institutions Holding XNCR

# of Institutions

216

Shares Held

71.8M

Call Options Held

2.5K

Put Options Held

7.9K

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.51B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account